• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BLOCK DRUG CO., INC. POLIDENT DOUBLE POWER; DENTURE CLEANSER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BLOCK DRUG CO., INC. POLIDENT DOUBLE POWER; DENTURE CLEANSER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Loss of consciousness (2418); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Death  
Manufacturer Narrative
Argus case: (b)(4).
 
Event Description
Foaming at mouth; loss of consciousness.Case description: this case was reported by a pharmacist via call center representative, and described the occurrence of accidental ingestion of product in a unk patient who received denture cleanser (polident double power) tablet (batch number unk, expiry date unknown) for an unknown indication.On an unknown date, the patient started polident double power (oral) at an unknown dose and frequency.On an unknown date, an unknown time after starting polident double power, the patient experienced accidental ingestion of product.The action taken with polident double power was unknown.On an unknown date, the outcome of the accidental ingestion of product was unknown.Clinical course: on an unknown date, the patient was transported to a hospital after accidentally taking 13 tablets of polident double power.Follow-up information received from the reporting pharmacist via sales rep on 21 october 2020.[clinical course] concurrent medical conditions included living in residential institution and dementia.On an unknown date, the patient with dementia living in a residential institution experienced foaming at mouth and loss of consciousness (serious criteria gsk medically significant) after accidentally taking 13 tablets of polident double power.The patient was transported to a general hospital.Details were unknown at present because it was hard to contact to icu due to covid-19.The patient's family calculated the number of tablets of polident double power as 13 from the remained ones.It was unknown if the patient actually took 13 tablets.On an unknown date, the outcome of the foaming at mouth and loss of consciousness were unknown.Reporter's comment: it was unknown if the reporter considered the foaming at mouth and loss of consciousness to be related to polident double power.
 
Event Description
Case description: this case was reported by a pharmacist via call center representative and described the occurrence of accidental ingestion of product in a unk patient who received denture cleanser (polident double power) tablet (batch number unk, expiry date unknown) for an unknown indication.On an unknown date, the patient started polident double power (oral) at an unknown dose and frequency.On an unknown date, an unknown time after starting polident double power, the patient experienced accidental ingestion of product.The action taken with polident double power was unknown.On an unknown date, the outcome of the accidental ingestion of product was unknown.Clinical course: on an unknown date, the patient was transported to a hospital after accidentally taking 13 tablets of polident double power.Follow-up information received from the reporting pharmacist via sales rep on 21 october 2020 clinical course: concurrent medical conditions included living in residential institution and dementia.On an unknown date, the patient with dementia living in a residential institution experienced foaming at mouth and loss of consciousness (serious criteria gsk medically significant) after accidentally taking 13 tablets of polident double power.The patient was transported to a general hospital.Details were unknown at present because it was hard to contact to icu due to covid-19.The patient's family calculated the number of tablets of polident double power as 13 from the remained ones.It was unknown if the patient actually took 13 tablets.On an unknown date, the outcome of the foaming at mouth and loss of consciousness were unknown.Reporter's comment: it was unknown if the reporter considered the foaming at mouth and loss of consciousness to be related to polident double power.Follow-up information received from the reporting pharmacist via medical representative on 14 january 2021 clinical course: on an unknown date, the patient experienced foaming at mouth and loss of consciousness (serious criteria death and gsk medically significant).On an unknown date, the outcome of the foaming at mouth and loss of consciousness were fatal.Reporter's comment: the reporter considered the foaming at mouth and loss of consciousness to be unrelated to polident double power.Pharmacist: unrelated.Physician: unrelated.No further information will be provided due to the refusal of the reporting pharmacist.Downgrade report.
 
Manufacturer Narrative
Argus case: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POLIDENT DOUBLE POWER
Type of Device
DENTURE CLEANSER
Manufacturer (Section D)
BLOCK DRUG CO., INC.
memphis
TN
MDR Report Key10822666
MDR Text Key216103879
Report Number1020379-2020-00056
Device Sequence Number1
Product Code EFT
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 10/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/21/2020
Initial Date FDA Received11/11/2020
Supplement Dates Manufacturer Received01/14/2021
Supplement Dates FDA Received01/18/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-